Horizon Therapeutics PLC (HZNP)

112.08 -0.90  -0.80% NASDAQ Oct 15, 16:00 112.09 +0.01  +0.01% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All HZNP News


View All Events


Date Type Description
11/03/2021 Earnings Results Q3 2021 Earnings Results
11/03/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
08/04/2021 Earnings Results Q2 2021 Earnings Results
08/04/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
04/29/2021 15:00 EST AGM 2020 Annual General Meeting
02/24/2021 Earnings Results Q4 2020 Earnings Results
02/24/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
11/02/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Horizon Therapeutics PLC is a specialty and generic drug manufacturing company. The company is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. The company has two reportable segments: orphan and rheumatology segment and the inflammation segment. It markets medicines in the areas of orphan diseases, rheumatology and inflammation division. The majority of revenue is generated in the United States.
  • URL: https://www.horizontherapeutics.com
  • Investor Relations URL: https://ir.horizontherapeutics.com
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Nov. 03, 2021
  • Last Earnings Release: Aug. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PTH Invesco DWA Healthcare Momentum ETF 4.60%
JCNIX Janus Henderson Contrarian S 4.23%
HQL Tekla Life Sciences Investors 3.86%
HQH Tekla Healthcare Investors 3.46%
CSMZX Carillon Scout Mid Cap Y 2.37%
DBMCX BNY Mellon Sm/Md Cp Gr C 2.23%
LIACX Columbia Acorn C 1.91%
FPX First Trust US Equity Opportunities ETF 1.79%
FXH First Trust Health Care AlphaDEX® ETF 1.64%
JMGQX JPMorgan Mid Cap Growth R4 1.29%
JGRJX JPMorgan Growth Advantage R2 1.00%
XBI SPDR® S&P Biotech ETF 0.79%





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.